423 related articles for article (PubMed ID: 36675282)
1. Seeing Neurodegeneration in a New Light Using Genetically Encoded Fluorescent Biosensors and iPSCs.
Stellon D; Talbot J; Hewitt AW; King AE; Cook AL
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675282
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas-Mediated Knock-in of Genetically Encoded Fluorescent Biosensors into the AAVS1 Locus of Human-Induced Pluripotent Stem Cells.
Stellon D; Tran MTN; Talbot J; Chear S; Khalid MKNM; Pébay A; Vickers JC; King AE; Hewitt AW; Cook AL
Methods Mol Biol; 2022; 2549():379-398. PubMed ID: 34505269
[TBL] [Abstract][Full Text] [Related]
3. Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegeneration.
Brandão-Teles C; Zuccoli GS; de Moraes Vrechi TA; Ramos-da-Silva L; Santos AVS; Crunfli F; Martins-de-Souza D
Biochem Soc Trans; 2024 Feb; 52(1):163-176. PubMed ID: 38288874
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of H
Ustyantseva E; Pavlova SV; Malakhova AA; Ustyantsev K; Zakian SM; Medvedev SP
Sci Rep; 2022 May; 12(1):8928. PubMed ID: 35624228
[TBL] [Abstract][Full Text] [Related]
5. Genetically Encoded Fluorescent Biosensors Illuminate the Spatiotemporal Regulation of Signaling Networks.
Greenwald EC; Mehta S; Zhang J
Chem Rev; 2018 Dec; 118(24):11707-11794. PubMed ID: 30550275
[TBL] [Abstract][Full Text] [Related]
6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
8. Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders.
Kumar M; Nguyen NTP; Milanese M; Bonanno G
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327542
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping Neurodegeneration in Human iPSCs.
Li J; Fraenkel E
Annu Rev Biomed Data Sci; 2021 Jul; 4():83-100. PubMed ID: 34465166
[TBL] [Abstract][Full Text] [Related]
10. A Platform for Studying Neurodegeneration Mechanisms Using Genetically Encoded Biosensors.
Ustyantseva EI; Medvedev SP; Vetchinova AS; Minina JM; Illarioshkin SN; Zakian SM
Biochemistry (Mosc); 2019 Mar; 84(3):299-309. PubMed ID: 31221068
[TBL] [Abstract][Full Text] [Related]
11. Genetically Encodable Fluorescent and Bioluminescent Biosensors Light Up Signaling Networks.
Zhou X; Mehta S; Zhang J
Trends Biochem Sci; 2020 Oct; 45(10):889-905. PubMed ID: 32660810
[TBL] [Abstract][Full Text] [Related]
12. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
14. Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration.
Linsley JW; Shah K; Castello N; Chan M; Haddad D; Doric Z; Wang S; Leks W; Mancini J; Oza V; Javaherian A; Nakamura K; Kokel D; Finkbeiner S
Nat Commun; 2021 Sep; 12(1):5284. PubMed ID: 34489414
[TBL] [Abstract][Full Text] [Related]
15. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
Albert K; Niskanen J; Kälvälä S; Lehtonen Š
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
[TBL] [Abstract][Full Text] [Related]
16. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
Cao L; Tan L; Jiang T; Zhu XC; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
[TBL] [Abstract][Full Text] [Related]
17. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
18. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases.
Peng J; Zeng X
Stem Cell Res Ther; 2011 Jul; 2(4):32. PubMed ID: 21861938
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
Gao A; Peng Y; Deng Y; Qing H
Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
[TBL] [Abstract][Full Text] [Related]
20. Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
Wang C; Ward ME; Chen R; Liu K; Tracy TE; Chen X; Xie M; Sohn PD; Ludwig C; Meyer-Franke A; Karch CM; Ding S; Gan L
Stem Cell Reports; 2017 Oct; 9(4):1221-1233. PubMed ID: 28966121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
